Latest updates for Immunotherapy

Fresh curated links around Immunotherapy are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Regulatory T cell reprogramming heads to trial in 2026
  • Scientists Advance Precision Cancer Immunotherapy
  • Preoperative Dual Immunotherapy Shows Promise in High-Risk Early HER2-Negative Breast Cancer

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

kevinmd.com /1 week ago

Regulatory T cell reprogramming heads to trial in 2026

Most people have heard of cancer immunotherapy by now. These treatments help a patient’s own immune system recognize and attack cancer. The best-known examples are immune checkpoin...

Read source
bioengineer.org /1 week ago

Scientists Advance Precision Cancer Immunotherapy

Cancer immunotherapy is entering a more controlled and technically sophisticated phase, according to a wide-ranging collection of studies and reviews that outline how researchers a...

Read source
bioengineer.org /1 month ago

Preoperative Dual Immunotherapy Shows Promise in High-Risk Early HER2-Negative Breast Cancer

WASHINGTON — A combination of two immunotherapy drugs produced substantially higher rates of tumor eradication when added to chemotherapy before surgery in patients with high-risk,...

Read source
rte.ie /1 month ago

Immunotherapy 'life changing' for family with allergies

The parent of children with severe food allergies has said discovering oral immunotherapy treatment has been "life changing" for her family.

Read source
bioengineer.org /1 month ago

Randomized Phase II Trial Tests Nivolumab Then Nivolumab-Ipilimumab or Docetaxel

A new randomized Phase II clinical trial, OPTIM, is testing whether escalating immune therapy can improve outcomes for people with recurrent or metastatic squamous cell carcinoma o...

Read source
bioengineer.org /2 weeks ago

Purdue compounds shown to stimulate powerful antitumor immune responses

Researchers at Purdue University have developed a small-molecule compound that could open a new route toward cancer immunotherapy by targeting a protein that normally restrains imm...

Read source
bioengineer.org /1 week ago

Nanoparticles Could Help Radiation Turn Cancer Immunity Into Durable Treatment

Radiotherapy may do more than destroy cancer cells at the site of treatment: it can also alert the immune system to the tumor. Yet that alarm is often too faint, too brief, or too...

Read source
scitechdaily.com /1 month ago

Ancient Immune Protein Could Hold the Key to Better Cancer Immunotherapy

A protein known for circulating in the blood to fight infection plays a very different role when produced by cells inside tumors. A protein that emerged long before animals develop...

Read source
bioengineer.org /1 month ago

Houston Methodist Researchers Create Biodegradable Implant for Targeted Cancer Immunotherapy

Houston Methodist Research Institute scientists have unveiled a biodegradable implant intended to deliver cancer-fighting immunotherapy drugs directly within tumors for prolonged p...

Read source
thehindubusinessline.com /1 month ago

Immuneel, Tata Memorial Centre partner to advance cell and gene therapy research

Among the first projects identified under the partnership is a Phase 2 extension study evaluating the safety and efficacy of IMN-003A cell therapy in adult and paediatric patients...

Read source
bioengineer.org /3 weeks ago

Sintilimab, IBI305, and Chemotherapy Show Promise in First-Line Advanced Gastric and GEJ Adenocarcinoma

Advanced gastric and gastroesophageal junction cancers are receiving renewed attention after researchers reported a clinical study testing a three-part first-line treatment strateg...

Read source
nanowerk.com /4 weeks ago

World's first oral microbiome-based nanomedicine to supercharge anti-cancer immunity

Engineered a DHB prodrug-based oral nano-emulsion with enhanced bioavailability, dramatically improving the efficacy of immune checkpoint blockade therapy.

Read source
sciencedaily.com /1 week ago

A cancer therapy put severe rheumatoid arthritis into remission

CAR T-cell therapy dramatically reduced disease activity in six people with severe rheumatoid arthritis that had resisted other treatments, with three achieving medication-free rem...

Read source
bioengineer.org /1 month ago

Survival Outcomes Linked to Timing of Immune Checkpoint Inhibitor Dosing

A new analysis from a large, single-centre cohort suggests that when immune checkpoint inhibitors are given can meaningfully shape outcomes for patients with advanced cancer. The s...

Read source
scitechdaily.com /1 month ago

New Tool Supercharges Immunotherapy Against Prostate Cancer

Prostate tumors can vanish from the immune system’s radar. Now, scientists have found a way to strip away that disguise by changing the length of a single RNA molecule. Researchers...

Read source
fiercebiotech.com /3 weeks ago

Tolerance Bio jumps into phase 2 with $260M deal for thymus-targeting fusion protein

Tolerance Bio has vaulted into the clinic by agreeing to pay NeoImmuneTech up to $260 million for rights to a fusion protein in certain thymus-related indications in the Americas a...

Read source
scitechdaily.com /1 month ago

New Strategy Could Break Pancreatic Cancer’s Protective Shield

A newly identified inflammatory signaling target may help weaken the protective environment surrounding pancreatic tumors and make existing treatments more effective. Pancreatic tu...

Read source
bioengineer.org /1 month ago

New Insights into Immune Checkpoints’ Role in Controlling Inflammation

Immune Checkpoints: Expanding Roles Beyond Cancer Immunotherapy Immune checkpoints (ICs) have long been recognized as critical regulators of T-cell activity within the tumor microe...

Read source
taz.de /1 month ago

Krebs besiegen: Neuer Kampfmodus freigeschaltet

Die eine Therapie, die Heilung gegen Krebs verspricht, gibt es nicht – aber Hoffnung, dass Immuntherapien uns ein gutes Stück nach vorn katapultieren. mehr...

Read source
bioengineer.org /1 month ago

Cemiplimab and fianlimab with neoadjuvant chemotherapy in early-stage high-risk -negative breast cancer

About the Study: Is combined inhibition of programmed cell death 1 protein (PD-1) and lymphocyte activation gene 3 (LAG-3) added to standard neoadjuvant chemotherapy (NAC) safe and...

Read source
futurity.org /1 week ago

Team finds way to ‘wake up’ tired immune cells

A new treatment is like a shot of espresso for "exhausted" immune systems. It could restore the body's defenses against cancer and infection.

Read source
aacr.org /1 month ago

What Is CAR T-cell Therapy?

With seven CAR T-cell therapies approved by the U.S. Food and Drug Administration, this innovative immunotherapy has revolutionized the treatment of blood cancers in recent years....

Read source
scientificamerican.com /1 month ago

Experimental immune therapy shows promise against deadly childhood brain cancer

Several children who had aggressive recurrent brain tumors remained disease-free years after this treatment, according to an early-stage trial

Read source
pharmexec.com /4 weeks ago

<![CDATA[The Science of Targeting Multiple Immune Components in ITP: Q&A with Dr. Srikanth Nagalla]]>

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Immunotherapy

feeds.feedburner.com

Recent coverage from public sources
Public source

rss.sciam.com

Recent coverage from public sources
Public source

bioengineer.org

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

taz.de

Recent coverage from public sources
Public source

aacr.org

Recent coverage from public sources
Public source